tiprankstipranks
Advertisement
Advertisement
Bioxyne to Outline Global Psychedelic and Cannabis Strategy at Coffee Microcaps Webinar
PremiumCompany AnnouncementsBioxyne to Outline Global Psychedelic and Cannabis Strategy at Coffee Microcaps Webinar
23d ago
Bioxyne seeks ASX quotation for nearly 7 million new shares
Premium
Company Announcements
Bioxyne seeks ASX quotation for nearly 7 million new shares
28d ago
Bioxyne to Consolidate Shares, Options and Performance Rights
Premium
Company Announcements
Bioxyne to Consolidate Shares, Options and Performance Rights
1M ago
Bioxyne Strikes Global Manufacturing Pact with Aurora Cannabis
PremiumCompany AnnouncementsBioxyne Strikes Global Manufacturing Pact with Aurora Cannabis
3M ago
Bioxyne Leverages Unique Licensing to Target Growing Psychedelic Medicine Demand
Premium
Company Announcements
Bioxyne Leverages Unique Licensing to Target Growing Psychedelic Medicine Demand
3M ago
Bioxyne to showcase expanding psychedelic and cannabis portfolio at virtual healthcare forum
Premium
Company Announcements
Bioxyne to showcase expanding psychedelic and cannabis portfolio at virtual healthcare forum
3M ago
Bioxyne Lifts FY26 Earnings Guidance After Strong First Half
PremiumCompany AnnouncementsBioxyne Lifts FY26 Earnings Guidance After Strong First Half
4M ago
Bioxyne Profit Surges as Revenue Nearly Triples on Alternative Therapeutics Push
Premium
Company Announcements
Bioxyne Profit Surges as Revenue Nearly Triples on Alternative Therapeutics Push
4M ago
Bioxyne Secures First Orders for GMP Psilocybin Capsules in Emerging Psychedelic Therapy Market
Premium
Company Announcements
Bioxyne Secures First Orders for GMP Psilocybin Capsules in Emerging Psychedelic Therapy Market
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100